Long-term outcomes in pulmonary arterial hypertension

被引：3
|
作者：
Thenappan, T. [1 ]
Palevsky, H. I. [2 ]
机构：
[1] Univ Chicago, Med Ctr, Dept Med, Cardiol Sect, Chicago, IL 60637 USA
[2] Univ Penn Hlth Syst, Penn Presbyterian Med Ctr, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2009年 / 63卷
关键词：
INTRAVENOUS EPOPROSTENOL; SURVIVAL; THERAPY; REGISTRY; ANTICOAGULANT; METAANALYSIS; BOSENTAN; TRIALS;
D O I：
10.1111/j.1742-1241.2009.02128.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：42 / 44
页数：3
相关论文
共 50 条
  • [1] Long-term therapeutic outcomes in pulmonary arterial hypertension
    Galie, Nazzareno
    Hirani, Naushad
    Manes, Alessandra
    Romanazzi, Serena
    Palazzini, Massimiliano
    Negro, Luca
    Branzi, Angelo
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S11 - S18
  • [2] Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension
    Blalock, Shannon E.
    Matulevicius, Susan
    Mitchell, Laura C.
    Reimold, Sharon
    Warner, John
    Peshock, Ronald
    Torres, Fernando
    Chin, Kelly M.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 121 - 127
  • [3] Treatment for children with idiopathic pulmonary arterial hypertension: Long-term survival and outcomes
    Yung, D
    Maislin, G
    Widlitz, A
    Rosenzweig, ESB
    Schmitt, K
    Brady, D
    O'Brien, E
    Kerstein, D
    Horn, EM
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 500A - 500A
  • [4] The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
    Wronski, Samantha L.
    Mordin, Margaret
    Kelley, Kim
    Anguiano, Rebekah H.
    Classi, Peter
    Shen, Eric
    Manaker, Scott
    LUNG, 2020, 198 (01) : 65 - 86
  • [5] Compelling Evidence of Long-Term Outcomes in Pulmonary Arterial Hypertension? A Clinical Perspective
    Gomberg-Maitland, Mardi
    Dufton, Christopher
    Oudiz, Ronald J.
    Benza, Raymond L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (09) : 1053 - 1061
  • [6] The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
    Samantha L. Wronski
    Margaret Mordin
    Kim Kelley
    Rebekah H. Anguiano
    Peter Classi
    Eric Shen
    Scott Manaker
    Lung, 2020, 198 : 65 - 86
  • [7] New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension
    Preston, Ioana R.
    Suissa, Samy
    Humbert, Marc
    EUROPEAN RESPIRATORY REVIEW, 2013, 22 (130): : 495 - 502
  • [8] The Long-Term Outcomes In Patients With Exercise-Induced Pulmonary Arterial Hypertension
    Huang, W.
    Systrom, D.
    Waxman, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Idiopathic Pulmonary Arterial Hypertension in Asians A Long-term Study on Clinical Outcomes
    Tan, Genevieve M. Y.
    Tay, Edgar L.
    Tai, Bee-Choo
    Yip, James W. L.
    CHEST, 2015, 147 (04) : E160 - E163
  • [10] Long-Term Intravenous Iloprost In Pulmonary Arterial Hypertension
    Ramjug, S.
    Hussain, N.
    Hamilton, N.
    Hurdman, J.
    Billings, C. G.
    Elliot, C.
    Kiely, D.
    Condliffe, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345